Nome |
# |
Long-term outcomes of chronic coronary syndrome worldwide: Insights from the international CLARIFY registry, file e309ade4-6cda-3969-e053-3a05fe0a2c94
|
1.007
|
Living alone and cardiovascular disease outcomes, file e309ade5-3e3d-3969-e053-3a05fe0a2c94
|
265
|
Uric acid and coronary artery disease: An elusive link deserving further attention, file e309ade0-ce37-3969-e053-3a05fe0a2c94
|
263
|
Left ventricular ejection fraction and heart failure: an indissoluble marriage?, file e309ade4-b2d0-3969-e053-3a05fe0a2c94
|
248
|
Cohort profile The ESC-EORP Chronic Ischemic Cardiovascular Disease Long-Term (CICD LT) registry, file e309ade5-01c2-3969-e053-3a05fe0a2c94
|
188
|
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry, file e309ade2-da28-3969-e053-3a05fe0a2c94
|
170
|
Anti-anginal drugs: Systematic review and clinical implications, file e309ade5-03d7-3969-e053-3a05fe0a2c94
|
170
|
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial, file e309ade2-4928-3969-e053-3a05fe0a2c94
|
120
|
Full Sternotomy, Hemisternotomy, and Minithoracotomy for Aortic Valve Surgery: Is There a Difference?, file e309ade4-cde5-3969-e053-3a05fe0a2c94
|
116
|
Ticagrelor Increases SIRT1 and HES1 mRNA Levels in Peripheral Blood Cells from Patients with Stable Coronary Artery Disease and Chronic Obstructive Pulmonary Disease, file e309ade2-d1c6-3969-e053-3a05fe0a2c94
|
115
|
2013 ESH/ESC Guidelines for the management of arterial hypertension, file e309ade2-c11f-3969-e053-3a05fe0a2c94
|
112
|
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction, file e309ade3-fc29-3969-e053-3a05fe0a2c94
|
105
|
Time course of endothelial dysfunction markers and mortality in COVID-19 patients: A pilot study, file 3c1b6127-ee0b-44e2-8eb5-3977b0b0acb7
|
102
|
New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma, file e309ade1-d88f-3969-e053-3a05fe0a2c94
|
97
|
SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials, file e309ade0-d130-3969-e053-3a05fe0a2c94
|
93
|
Heart failure with preserved ejection fraction: uncertainties and dilemmas, file e309ade0-ce25-3969-e053-3a05fe0a2c94
|
91
|
Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry, file e309ade3-4a4a-3969-e053-3a05fe0a2c94
|
91
|
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions, file e309ade3-4b60-3969-e053-3a05fe0a2c94
|
91
|
Relations between professional medical associations and the health-care industry, concerning scientific communication and continuing medical education: a Policy Statement from the European Society of Cardiology, file e309ade0-4b31-3969-e053-3a05fe0a2c94
|
88
|
KRIT1 deficiency promotes aortic endothelial dysfunction, file e309ade2-a6e3-3969-e053-3a05fe0a2c94
|
84
|
Distinct gene expression profiles associated with Notch ligands Delta-like 4 and Jagged1 in plaque material from peripheral artery disease patients: A pilot study, file e309ade2-a03b-3969-e053-3a05fe0a2c94
|
80
|
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis, file e309ade2-da5f-3969-e053-3a05fe0a2c94
|
79
|
A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics, file e309ade4-7fe0-3969-e053-3a05fe0a2c94
|
77
|
Estrogen receptor β-dependent Notch1 activation protects vascular endothelium against tumor necrosis factor α (TNFα)-induced apoptosis, file e309ade2-a6d9-3969-e053-3a05fe0a2c94
|
76
|
Exosome in Cardiovascular Diseases: A Complex World Full of Hope, file e309ade2-d24c-3969-e053-3a05fe0a2c94
|
76
|
Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease, file e309ade4-957c-3969-e053-3a05fe0a2c94
|
76
|
Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study, file e309ade2-e124-3969-e053-3a05fe0a2c94
|
73
|
Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry, file e309ade4-ae96-3969-e053-3a05fe0a2c94
|
69
|
Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban
in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudy, file e309ade0-367b-3969-e053-3a05fe0a2c94
|
67
|
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis, file e309ade3-3fd8-3969-e053-3a05fe0a2c94
|
67
|
In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry, file e309ade4-88cb-3969-e053-3a05fe0a2c94
|
65
|
Beyond cardiomyocyte loss: Role of Notch in cardiac aging, file e309ade5-1be8-3969-e053-3a05fe0a2c94
|
65
|
Beta-blockers and COPD: how can harmony be restored in a marriage in crisis?, file e309ade3-5a79-3969-e053-3a05fe0a2c94
|
64
|
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease, file e309ade3-9a5e-3969-e053-3a05fe0a2c94
|
64
|
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation, file e309ade3-4fb5-3969-e053-3a05fe0a2c94
|
63
|
Aortic valve stenosis and mitochondrial dysfunctions: Clinical and molecular perspectives, file e309ade3-1f5d-3969-e053-3a05fe0a2c94
|
62
|
Studio dei progenitori emopoietici circolanti in pazienti con infarto del miocardio, file e309ade4-1a6a-3969-e053-3a05fe0a2c94
|
61
|
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF), file e309ade4-9725-3969-e053-3a05fe0a2c94
|
60
|
In vivo targeting of de novo DNA methylation by histone modifications in yeast and mouse, file e309ade3-4bef-3969-e053-3a05fe0a2c94
|
55
|
What Happened to Electrocardiogram as a Screening Test to Recognize Cardiovascular Complications in COVID-19 Patients?, file e309ade4-cc03-3969-e053-3a05fe0a2c94
|
53
|
The role of notch in the cardiovascular system: potential adverse effects of investigational notch inhibitors, file e309ade1-33db-3969-e053-3a05fe0a2c94
|
52
|
Acute heart failure: lessons learned, roads ahead, file e309ade4-d52b-3969-e053-3a05fe0a2c94
|
52
|
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT), file e309ade0-d466-3969-e053-3a05fe0a2c94
|
51
|
Lamin A/C Missense Mutation R216C Pinpoints Overlapping Features Between Brugada Syndrome and Laminopathies, file e309ade2-9ddb-3969-e053-3a05fe0a2c94
|
50
|
Relationships between Components of Blood Pressure and Cardiovascular Events in Patients with Stable Coronary Artery Disease and Hypertension, file e309ade4-8a7e-3969-e053-3a05fe0a2c94
|
50
|
Long-term outcomes of chronic coronary syndrome worldwide: Insights from the international CLARIFY registry, file e309ade4-6cd9-3969-e053-3a05fe0a2c94
|
48
|
Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry, file e309ade4-ac70-3969-e053-3a05fe0a2c94
|
47
|
The story of the heartbeat, continued, file e309ade4-b72b-3969-e053-3a05fe0a2c94
|
47
|
The multifaceted angina, file e309ade4-9339-3969-e053-3a05fe0a2c94
|
46
|
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial, file e309ade4-9506-3969-e053-3a05fe0a2c94
|
46
|
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure, file e309ade4-d385-3969-e053-3a05fe0a2c94
|
46
|
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome, file e7391ba1-d6ee-4c32-ae1a-aab605199013
|
46
|
The Notch pathway: a novel therapeutic target for cardiovascular diseases?, file e309ade2-33bd-3969-e053-3a05fe0a2c94
|
45
|
Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: An insight into the mechanisms of cardiac involvement, file e309ade4-785b-3969-e053-3a05fe0a2c94
|
45
|
Effects of Serelaxin in Patients with Acute Heart Failure, file e309ade4-d22f-3969-e053-3a05fe0a2c94
|
45
|
Polar plot maps by parametric strain echocardiography allow accurate evaluation of non-viable transmural scar tissue in ischaemic heart disease, file e309ade0-d89a-3969-e053-3a05fe0a2c94
|
44
|
COX-2 is downregulated in human stenotic aortic valves and its inhibition promotes dystrophic calcification, file e309ade3-4d5f-3969-e053-3a05fe0a2c94
|
44
|
Differential role of circulating microRNAs to track progression and pre-symptomatic stage of chronic heart failure: A pilot study, file e309ade3-5782-3969-e053-3a05fe0a2c94
|
44
|
Hemoglobin and Change in Hemoglobin Status Predict Mortality, Cardiovascular Events, and Bleeding in Stable Coronary Artery Disease, file e309ade4-ca22-3969-e053-3a05fe0a2c94
|
44
|
Angina and chronic obstructive pulmonary disease: facing the perfect storm, file e309ade4-933a-3969-e053-3a05fe0a2c94
|
43
|
beta-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study, file e309ade4-7f6a-3969-e053-3a05fe0a2c94
|
42
|
Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry, file e309ade0-d5db-3969-e053-3a05fe0a2c94
|
41
|
Multiparametric flow cytometric characterization of circulating stem cell subsets in patients with myocardial infarction: correlation with clinical and biological data, file e309ade4-3ab6-3969-e053-3a05fe0a2c94
|
41
|
The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease, file e309ade0-395c-3969-e053-3a05fe0a2c94
|
40
|
COVID-19 in the heart and the lungs: could we “Notch” the inflammatory storm?, file e309ade4-96dc-3969-e053-3a05fe0a2c94
|
40
|
Effectiveness of a novel nutraceutical compound containing red yeast rice, polymethoxyflavones and antioxidants in the modulation of cholesterol levels in subjects with hypercholesterolemia and low-moderate cardiovascular risk: The NIRVANA study, file e309ade2-378f-3969-e053-3a05fe0a2c94
|
39
|
New onset of chest pain: the importance of remote monitoring, file e309ade4-92c6-3969-e053-3a05fe0a2c94
|
39
|
Priorities for Cath labs in the COVID-19 tsunami; Roberto Ferrari and co-authors present a procedure to follow subsequent to the outbreak in Italy, file e309ade4-cc01-3969-e053-3a05fe0a2c94
|
39
|
Treating angina, file e309ade4-e61f-3969-e053-3a05fe0a2c94
|
39
|
Understanding ARNIs, file e309ade5-0b97-3969-e053-3a05fe0a2c94
|
39
|
Role of ivabradine in management of stable angina in patients with different clinical profiles, file e309ade5-20ea-3969-e053-3a05fe0a2c94
|
38
|
Angina and left ventricular dysfunction: can we "reduce' it?, file e309ade4-b9bc-3969-e053-3a05fe0a2c94
|
37
|
CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: systematic review and individual patient pooled meta-analysis, file e309ade5-22e2-3969-e053-3a05fe0a2c94
|
37
|
Circulating stem cells vary with NYHA stage in heart failure patients, file e309ade4-a811-3969-e053-3a05fe0a2c94
|
36
|
The story of the heartbeat, II, file e309ade4-cb2a-3969-e053-3a05fe0a2c94
|
35
|
Are all children born the same?, file e309ade4-e34b-3969-e053-3a05fe0a2c94
|
35
|
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings, file e309ade4-2fdf-3969-e053-3a05fe0a2c94
|
34
|
Predictors of cardiac arrhythmic events in non coronary artery disease patients, file e309ade4-d848-3969-e053-3a05fe0a2c94
|
32
|
Beyond cardiomyocyte loss: Role of Notch in cardiac aging, file e309ade5-0b54-3969-e053-3a05fe0a2c94
|
32
|
Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment, file e309ade2-dd69-3969-e053-3a05fe0a2c94
|
29
|
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker?, file e309ade3-f8b8-3969-e053-3a05fe0a2c94
|
28
|
Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study, file e309ade2-b305-3969-e053-3a05fe0a2c94
|
25
|
ARNIs: balancing “the good and the bad” of neuroendocrine response to HF, file e309ade2-c37b-3969-e053-3a05fe0a2c94
|
24
|
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study), file e309ade0-21e7-3969-e053-3a05fe0a2c94
|
21
|
Similarities between fibroblasts and cardiomyocytes in the study of the permeability transition pore, file e309ade5-7a55-3969-e053-3a05fe0a2c94
|
21
|
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease, file e309ade3-cfc2-3969-e053-3a05fe0a2c94
|
16
|
The battle against COVID-19: Mortality in Italy, file 0dae2ad8-2837-46e6-a7ca-275a0af8ff0f
|
15
|
Can we improve myocardial protection during ischaemic injury?, file e309ade0-cf79-3969-e053-3a05fe0a2c94
|
15
|
Phenotypic heterogeneity of COVID-19 pneumonia: clinical and pathophysiological relevance of the vascular phenotypea, file 62c5c5bf-e93c-4d89-9ce2-4a7d2c2cc887
|
14
|
Blood pressure reduction and clinical outcomes with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: Protocol for a systematic review and meta-regression analysis, file e309ade5-2855-3969-e053-3a05fe0a2c94
|
14
|
Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19, file 1ab46a97-579f-4947-b659-7f77fc80e661
|
12
|
Standard ecg in brugada syndrome as a marker of prognosis: From risk stratification to pathophysiological insights, file 392fe7e1-654a-4ec0-9b90-38a0a973f26d
|
12
|
The 'Black Death' and the physician at the time of COVID-19, file e309ade3-a5c3-3969-e053-3a05fe0a2c94
|
12
|
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT), file e309ade4-1657-3969-e053-3a05fe0a2c94
|
12
|
'Corona' versus 'coronary', file e309ade3-d8de-3969-e053-3a05fe0a2c94
|
11
|
Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: An analysis from the SIGNIFY study, file e309ade2-df12-3969-e053-3a05fe0a2c94
|
10
|
Adapting to survive, file e309ade3-da75-3969-e053-3a05fe0a2c94
|
10
|
2019 CORONAVIRUS: What are the implications for cardiology?, file 46a107dd-32f2-44a6-adb7-4a44aa7de448
|
9
|
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients, file 95a7ad4a-44e5-46e9-a8fd-0ced46c0864a
|
9
|
Efficacy of perindopril in reducing risk of cardiac events in patients with revascularized coronary artery disease, file e309ade0-2922-3969-e053-3a05fe0a2c94
|
8
|
Totale |
6.945 |